Sign In
CRISM Therapeutics Corporation plc (AIM: CRTX)*: Positive preclinical data for its second asset, Docetaxel-ChemoSeed in prostate cancer modelCardiogeni plc (AQSE: CGNI): Completion of share agreement with Kira Health
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Crism Thera (CRTX)
Follow the stocks
